ShouTi grabs $100m Series B

ShouTi Inc., a clinical-stage biopharmaceutical company, has secured $100 million in Series B financing. BVF Partners led the round with participation from other backers that included Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners and Stork Capital.

Source: Press Release